Integrating conventional and antibody-based targeted anticancer treatment into immunotherapy

In advanced cancer, current conventional therapies or immunotherapies cannot eradicate all tumor cells for most patients. Integration of these two treatments for synergistic effects could eradicate more tumor cells and increase overall survival rates. But proper integration is a challenge, partly du...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Meng Michelle, Pu, Yang, Weichselbaum, Ralph R., Fu, Yang-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5243926/
https://www.ncbi.nlm.nih.gov/pubmed/27425593
http://dx.doi.org/10.1038/onc.2016.231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5243926/
https://www.ncbi.nlm.nih.gov/pubmed/27425593
http://dx.doi.org/10.1038/onc.2016.231

Ejemplares similares